Patient considerations and clinical impact of cholesteryl ester transfer protein inhibitors in the management of dyslipidemia: focus on anacetrapib

Overview of attention for article published in Vascular Health and Risk Management, August 2012

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 27 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Dyslipidemia therapeutic agent

Grant US-9968592-B2

United States of America